Cited by 405Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.

Regulation of cancer cell metabolism: oncogenic MYC in the driver’s seat

Open access

Dong, Yang, Tu, Rongfu, Liu, Hudan, Qing, Guoliang·2020·Signal Transduction and Targeted Therapy

DOI 10.1038/s41392-020-00235-2PMC PMC7351732

Open this paper in CoChat — free account Open PDF

Abstract

Cancer cells must rewire cellular metabolism to satisfy the demands of unbridled growth and proliferation. As such, most human cancers differ from normal counterpart tissues by a plethora of energetic and metabolic reprogramming. Transcription factors of the MYC family are deregulated in up to 70% of all human cancers through a variety of mechanisms. Oncogenic levels of MYC regulates almost every aspect of cellular metabolism, a recently revisited hallmark of cancer development. Meanwhile, unrestrained growth in response to oncogenic MYC expression creates dependency on MYC-driven metabolic pathways, which in principle provides novel targets for development of effective cancer therapeutics. In the current review, we summarize the significant progress made toward understanding how MYC deregulation fuels metabolic rewiring in malignant transformation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41392-020-00235-2

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 MYC coordinates global metabolic reprogramming. Deregulation of MYC frequently occurs in human cancers through a variety of mechanisms, such as chromosome amplification/translocation, super-enhancer activation, and aberrant upstream signaling. MYC deregulation rewires multiple metabolic pathways to generate energy, building blocks, and reducing power for growing tumor cells. EAA essential amino acidCC BY · PubMed Central

Fig. 2 MYC regulation of glucose, glutamine, and proline metabolism. MYC promotes glucose metabolism by upregulating glucose transporters and nearly all the glycolytic enzymes. MYC ellicts glutamine addiction by promoting glutamine uptake and glutaminolysis. MYC promotes proline anabolism and represses its catabolism. Enzymes labeled in red are upregulated by MYC, and those labeled in green are suppressed by MYC. α-KG α-ketoglutarate, ALDOA aldolase A, 1,3BPG 1,3-bisphosphoglycerate, Cit citrate, ENO enolase, F1,6-BP fructose 1,6-bisphosphate, F6P fructose 6-phosphate, GA3P glyceraldehyde-3-phosphate, GAPDH glyceraldehyde-3-phosphate dehydrogenase, Gln glutamine, GLS glutaminase, Glu glutamate, GOT2 glutamate oxaloacetate transaminase, G6P glucose-6-phosphate, GPI phosphoglucose isomerase, GPT glutamine pyruvate transaminase, GS glutamine synthetase, GSA glutamic-γ-semialdehyde, HK hexokinase, LDHA lactate dehydrogenase A, Mal malate, MCT monocarboxylate transporter, P5C Δ1-pyyroline-5-carboxylate, P5CDH P5C dehydrogenase, P5CS P5C synthase, PDH pyruvate dehydrogenase, PEP phosphoenolpyruvate, PFK phosphofructokinase, PG phosphoglycerate, PGK phosphoglycerate kinase, PGM phosphoglucomutase, PKM2 pyruvate kinase M2, POX/PRODH proline oxidase/dehydrogenase, Pro proline, PYCR P5C reductase, Pyr pyruvate, SLC solute carrier family, Suc succinate, TCA tricarboxylic acidCC BY · PubMed Central

Fig. 3 MYC regulation of essential amino acid and lipid metabolism. MYC activates critical transporters, SLC7A5, SLC43A1, and SLC1A5, to promote essential amino acid transport. BCAT1, which catalyzes the decomposition of branched amino acids, is a downstream target of MYC. MYC promotes tryptophan uptake and metabolism by the kynurenine pathway. MYC coordinates glucose, glutamine, and essential amino acid metabolism to promote fatty acid biosynthesis. Enzymes labeled in red are upregulated by MYC. ACC acetyl-coA carboxylase, ACLY ATP citrate lyase, AFMID arylformamidase, BCAA branched-chain amino acid BCAT branched-chain aminotransferase, BCKA branched-chain α-keto acid, FA fatty acid, FASN fatty acid synthase, Fum fumarate, His histidine, HMG-CoA 3-hydroxy-3-methylglutaryl-CoA, HMGCR 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, Ile isoleucine, KMO kynurenine-3-monooxygenase, Kyn kynurenine, KYNU kynureninase, Leu leucine, Met methionine, OAA oxaloacetate, Phe phenylalanine, SCD stearoyl-CoA desaturase, Thr threonine, Trp tryptophan, Val valineCC BY · PubMed Central

Fig. 4 MYC coordinates multiple metabolic events to activate nucleotide metabolism. MYC activates ODC, SMS, and SRM to promote polyamine biosynthesis. MYC drives nucleotide biosynthesis (1) by facilitating generation of PRPP, which offers skeleton for de novo purine and pyrimidine biosynthesis; (2) by facilitating generation of serine and glycine, which offers one-carbon unit for folate cycle; and (3) by directly inducing enzymes involved in de novo nucleotide biosynthesis. Enzymes labeled in red are upregulated by MYC. ARG1 arginase 1, AMP adenosine monophosphate, CAD carbamoyl-phosphate synthetase; CDP cytosine diphosphate; CHOTHF formyl tetrahydrofolate; CH2THF 5,10-methylene tetrahydrofolate; CH3THF methyl tetrahydrofolate, CTP cytosine triphosphate, dcSAM decarboxylated S-adenosyl-methionine, DHO dihydroorotate, DHODH dihydroorotate dehydrogenase, DHF dihydrofolate, dUDP deoxyuridine diphosphate, dTMP deoxythymidine monophosphate, Gly glycine, GMPS guanosine monophosphate synthetase, G6PD glucose-6-phosphate dehydrogenase, IMP inosine monophosphate, IMPDH inosine-5′-monophosphate dehydrogenase, MTA 5′-methylthioadenosine, MTR 5-methylthioribose-1-phosphate, ODC ornithine decarboxylase, OMP orotate monophosphate, PHGDH phosphoglycerate dehydrogenase, PPAT phosphoribosyl pyrophosphate amidotransferase, PPP pentose phosphate pathway, PRA 5-phosphoribosylamine, PRPP phosphoribosyl pyrophosphate, PRPS pyrophosphate synthetase, PSAT phosphoserine aminotransferase, PSPH phosphate ester hydrolysis, PUT putrescine, R5P ribose 5-phosphate, SAM S-adenosyl methionine, Ser serine, SHMT serine hydroxymethyltransferase, SMS spermine synthase, SPD spermidine, SPM spermine, SRM spermidine synthase, THF tetrahydrofolate, Tkt transketolase, TS thymidylate synthase, UDP uridine diphosphate, UTP uridine triphosphateCC BY · PubMed Central

Fig. 5 Metabolic regulation of MYC expression and transcriptional activity. Expression of MYC is downstream of multiple control mechanisms, as shown in a–d, which are regulated by nutrient levels and respond to metabolic stress. See text for more details. AMPK AMP-activated protein kinase, B55α also termed Ppp2r2a, a specific B subunit of PP2A, EDD E3 identified by differential display, eIF eukaryotic initiation factor, FOXOs forkhead transcription factors of the O class, GCN2 general control non-derepressible-2, OGT O-linked N-acetylglucosamine transferase, PI3K phosphatidylinositol 3-kinase, S6K1 effector S6 kinase 1, URI unconventional prefoldin RPB5 interactorCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: The mTORC1/S6K1 Pathway Regulates Glutamine Metabolism through the eIF4B-Dependent Control of c-Myc Translation
Csibi, A., Lee, G., Yoon, S.-O., Tong, H., Ilter, D., Elia, I., Fendt, S., Roberts, T. M., & Blenis, J. (2014) · Current Biology · doi:10.1016/j.cub.2014.08.007 · Cited by 253
Retracted
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
MYC on the Path to Cancer
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Jagt, D. L. V., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,528
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
Gross, M. I., Demo, S. D., Dennison, J. B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J. R., Laidig, G. J., Lewis, E. R., Li, J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0870 · Cited by 1,068
Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs
Metcalf, B. W., Bey, P., Danzin, C., Jung, M. J., Casara, P., & Vevert, J. (1978) · Journal of the American Chemical Society · doi:10.1021/ja00476a050 · Cited by 1,005
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D. R., Lee, L. A., & Dang, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000023200 · Cited by 876
The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor
Greer, E. L., Oskoui, P. R., Banko, M. R., Maniar, J. M., Gygi, M. P., Gygi, S. P., & Brunet, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705325200 · Cited by 852
Modelling Myc inhibition as a cancer therapy
Soucek, L., Whitfield, J. R., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., Karnezis, A. N., Swigart, L. B., Nasi, S., & Evan, G. I. (2008) · Nature · doi:10.1038/nature07260 · Cited by 846
p53 represses c-Myc through induction of the tumor suppressor miR-145
Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S. R., Elble, R. C., Watabe, K., & Mo, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808042106 · Cited by 841
Targeting oncogenic Myc as a strategy for cancer treatment
Chen, H., Liu, H., & Qing, G. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0008-7 · Cited by 834
Self-citation
The ornithine decarboxylase gene is a transcriptional target of c-Myc.
Bello-Fernández, C., Packham, G., & Cleveland, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7804 · Cited by 787
The purine path to chemotherapy
Elion, G. B. (1989) · Science · doi:10.1126/science.2649979 · Cited by 687
Serine is a natural ligand and allosteric activator of pyruvate kinase M2
Chaneton, B., Hillmann, P., Zheng, L., Martin, A. C. L., Maddocks, O. D. K., Chokkathukalam, A., Coyle, J. E., Jankevics, A., Holding, F. P., Vousden, K. H., et al. (2012) · Nature · doi:10.1038/nature11540 · Cited by 661
Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
Kim, J.-W., Gao, P., Liu, Y.-C., Semenza, G. L., & Dang, C. V. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00440-07 · Cited by 658
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Puissant, A., Frumm, S. M., Alexe, G., Bassil, C. F., Qi, J., Chanthery, Y. H., Nekritz, E. A., Zeid, R., Gustafson, W. C., Greninger, P., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0418 · Cited by 648
Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells
Hosios, A. M., Hecht, V. C., Danai, L. V., Johnson, M. O., Rathmell, J. C., Steinhauser, M. L., Manalis, S. R., & Vander Heiden, M. G. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.02.012 · Cited by 641
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type
Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.015 · Cited by 639
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature · doi:10.1038/nature13485 · Cited by 635
MYC, Metabolism, Cell Growth, and TumorigenesisPreprint
Dang, C. V. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014217 · Cited by 625
Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line
Collins, S. J., & Groudine, M. T. (1982) · Nature · doi:10.1038/298679a0 · Cited by 613
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
Otto, T., Horn, S., Brockmann, M., Eilers, U., Schüttrumpf, L., Popov, N., Kenney, A. M., Schulte, J. H., Beijersbergen, R. L., Christiansen, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.005 · Cited by 576
Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models
Svensson, R. U., Parker, S. J., Eichner, L. J., Kolar, M. J., Wallace, M., Brun, S. N., Lombardo, P. S., Van Nostrand, J. L., Hutchins, A., Vera, L., et al. (2016) · Nature Medicine · doi:10.1038/nm.4181 · Cited by 536
A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells
Li, Z., Calcar, S. V., Qu, C., Cavenee, W. K., Zhang, M. Q., & Ren, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332764100 · Cited by 528
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Camarda, R., Zhou, A. Y., Kohnz, R. A., Balakrishnan, S., Mahieu, C. I., Anderton, B. N., Eyob, H., Kajimura, S., Tward, A. D., Krings, G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4055 · Cited by 528
Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC
Liu, W., Le, A., Hancock, C., Lane, A. N., Dang, C. V., Fan, T. W.-M., & Phang, J. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203244109 · Cited by 483
2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
Zhang, D., Li, J., Wang, F., Hu, J. X., Wang, S., & Sun, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.003 · Cited by 477
c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas
Chou, T.-Y., Hart, G. W., & Dang, C. V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18961 · Cited by 453
Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia
Ye, J., Fan, J., Venneti, S., Wan, Y.-W., Pawel, B. R., Zhang, J., Finley, L. W. S., Lu, C., Lindsten, T., Cross, J. R., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0250 · Cited by 452
Self-citation
Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia
Hattori, A., Tsunoda, M., Konuma, T., Kobayashi, M., Nagy, T., Glushka, J., Tayyari, F., McSkimming, D., Kannan, N., Tojo, A., et al. (2017) · Nature · doi:10.1038/nature22314 · Cited by 401
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Polański, R., Hodgkinson, C. L., Fusi, A., Nonaka, D., Priest, L., Kelly, P., Trapani, F., Bishop, P. W., White, A., Critchlow, S. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2270 · Cited by 378
ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
Qing, G., Li, B., Vu, A., Skuli, N., Walton, Z. E., Liu, X., Mayes, P. A., Wise, D. R., Thompson, C. B., Maris, J. M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.021 · Cited by 375
Self-citation
Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays
Kim, J.-W., Zeller, K. I., Wang, Y., Jegga, A. G., Aronow, B. J., O'Donnell, K. A., & Dang, C. V. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5923-5936.2004 · Cited by 371
FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression
Ferber, E. C., Peck, B., Delpuech, O., Bell, G. P., East, P., & Schulze, A. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.179 · Cited by 320
cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions
Sun, L., Song, L., Wan, Q., Wu, G., Li, X., Wang, Y., Wang, J., Liu, Z., Zhong, X., He, X., et al. (2015) · Cell Research · doi:10.1038/cr.2015.33 · Cited by 313
Interaction of dihydrofolate reductase with methotrexate: Ensemble and single-molecule kinetics
Rajagopalan, P. T. R., Zhang, Z., McCourt, L., Dwyer, M., Benkovic, S. J., & Hammes, G. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172501499 · Cited by 295
l ‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth
Oda, K., Hosoda, N., Endô, H., SAITO, K., Tsujihara, K., Yamamura, M., Sakata, T., Anzai, N., Wempe, M. F., Kanai, Y., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01386.x · Cited by 288
Metabolic maintenance of cell asymmetry following division in activated T lymphocytes
Verbist, K., Guy, C. S., Milasta, S., Liedmann, S., Kamiński, M. M., Wang, R., & Green, D. R. (2016) · Nature · doi:10.1038/nature17442 · Cited by 273
ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
Hogarty, M. D., Norris, M. D., Davis, K., Liu, X., Evageliou, N. F., Hayes, C. S., Pawel, B., Guo, R. J., Zhao, H., Sekyere, E. O., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6866 · Cited by 263
Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer
Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D. (2014) · Cell · doi:10.1016/j.cell.2014.03.052 · Cited by 260
MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancerPreprint
Venkateswaran, N., Lafita‐Navarro, M. C., Hao, Y.-H., Kilgore, J. A., Perez‐Castro, L., Braverman, J., Borenstein‐Auerbach, N., Kim, M. G., Lesner, N. P., Mishra, P., et al. (2019) · Genes & Development · doi:10.1101/gad.327056.119 · Cited by 260
Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation
Bott, A. J., Peng, I., Fan, Y., Faubert, B., Zhao, L. H., Li, J., Neidler, S., Sun, Y., Jaber, N. L., Krokowski, D., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.025 · Cited by 259
Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells
Mannava, S., Grachtchouk, V., Wheeler, L. J., Im, M., Zhuang, D., Slavina, E. G., Mathews, C. K., Shewach, D. S., & Nikiforov, M. A. (2008) · Cell Cycle · doi:10.4161/cc.6390 · Cited by 257
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
Shroff, E. H., Eberlin, L. S., Dang, V. M., Gouw, A. M., Gabay, M., Adam, S. J., Bellovin, D. I., Tran, P. T., Philbrick, W. M., Garcia-Ocana, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507228112 · Cited by 255
MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
Zirath, H., Frenzel, A., Oliynyk, G., Segerström, L., Westermark, U., Larsson, K., Persson, M. M., Hultenby, K. R., Lehtiö, J., Einvik, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222404110 · Cited by 229
Myc‐induced proliferation and transformation require Akt‐mediated phosphorylation of FoxO proteins
Bouchard, C., Marquardt, J., Brás, A., Medema, R. H., & Eilers, M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600279 · Cited by 220
HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5
Elorza, A., Soro-Arnáiz, I., Meléndez‐Rodríguez, F., Rodríguez-Vaello, V., Marsboom, G., de Cárcer, G., Acosta‐Iborra, B., Albacete-Albacete, L., Ordóñez, Á., Serrano‐Oviedo, L., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.017 · Cited by 212
Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
Shen, L., O’Shea, J. M., Kaadige, M. R., Cunha, S., Wilde, B. R., Cohen, A. L., Welm, A. L., & Ayer, D. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501555112 · Cited by 212
The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1
Hansen, C. G., Ng, Y. L. D., Lam, W.-L. M., Plouffe, S. W., & Guan, K.-L. (2015) · Cell Research · doi:10.1038/cr.2015.140 · Cited by 212
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation
Nilsson, J. A., Keller, U. B., Baudino, T. A., Yang, C., Norton, S., Old, J. B., Nilsson, L. M., Neale, G. A. M., Kramer, D. L., Porter, C. W., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.036 · Cited by 210
Purine synthesis promotes maintenance of brain tumor initiating cells in glioma
Wang, X., Yang, K., Xie, Q., Wu, Q., Mack, S. C., Shi, Y., Kim, L. J. Y., Prager, B. C., Flavahan, W. A., Liu, X., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4537 · Cited by 206
Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis
Carroll, P. A., Diolaiti, D., McFerrin, L. G., Gu, H., Djukovic, D., Du, J., Cheng, P. F., Anderson, S., Ulrich, M. L., Hurley, J. B., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.024 · Cited by 202
A Functional Screen for Myc-Responsive Genes Reveals Serine Hydroxymethyltransferase, a Major Source of the One-Carbon Unit for Cell Metabolism
Nikiforov, M. A., Chandriani, S. J., O’Connell, B. C., Petrenko, O., Kotenko, I., Beavis, A. J., Sedivy, J. M., & Cole, M. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5793-5800.2002 · Cited by 201
Oncogenic MYC Activates a Feedforward Regulatory Loop Promoting Essential Amino Acid Metabolism and Tumorigenesis
Yue, M., Jiang, J., Gao, P., Liu, H., & Qing, G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.12.002 · Cited by 201
Self-citation
Correlation of L‐type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis
Furuya, M., Horiguchi, J., Nakajima, H., Kanai, Y., & Oyama, T. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02151.x · Cited by 195
The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth
Gouw, A. M., Margulis, K., Liu, N. S., Raman, S. J., Mancuso, A., Toal, G. G., Tong, L., Mosley, A. R., Hsieh, A. L., Sullivan, D. K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.012 · Cited by 195
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis
Pin, L., Ge, M., Hu, J., Li, X., Che, L., Sun, K., Cheng, L., Huang, Y., Pilo, M. G., Cigliano, A., et al. (2017) · Hepatology · doi:10.1002/hep.29183 · Cited by 188
MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
Cao, Z., Fan-Minogue, H., Bellovin, D. I., Yevtodiyenko, A., Arzeno, J., Yang, Q., Gambhir, S. S., & Felsher, D. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3367 · Cited by 181
Targeting Amino Acid Transport in Metastatic Castration-Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development
Wang, Q., Tiffen, J. C., Bailey, C. G., Lehman, M., Ritchie, W., Fazli, L., Metierre, C., Feng, Y., Li, E., Gleave, M. E., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt241 · Cited by 175
Proline biosynthesis augments tumor cell growth and aerobic glycolysis: involvement of pyridine nucleotides
Liu, W., Hancock, C. N., Fischer, J. W., Harman, M., & Phang, J. M. (2015) · Scientific Reports · doi:10.1038/srep17206 · Cited by 175
Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival
Xiao, D., Yue, M., Su, H., Ren, P., Jiang, J., Li, F., Hu, Y., Du, H., Liu, H., & Qing, G. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.016 · Cited by 174
Self-citation
Role of the Transcription Factor ATF4 in the Anabolic Actions of Insulin and the Anti-anabolic Actions of Glucocorticoids
Adams, C. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610510200 · Cited by 173
The purine path to chemotherapy
Elion, G. B. (1989) · Bioscience Reports · doi:10.1007/bf01119794 · Cited by 169
Androgen Receptor and Nutrient Signaling Pathways Coordinate the Demand for Increased Amino Acid Transport during Prostate Cancer Progression
Wang, Q., Bailey, C. G., Ng, C., Tiffen, J. C., Thoeng, A., Minhas, V., Lehman, M., Hendy, S. C., Buchanan, G., Nelson, C. C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1821 · Cited by 168
c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry
Morrish, F. M., Isern, N., Sadı́lek, M., Jeffrey, M., & Hockenbery, D. M. (2009) · Oncogene · doi:10.1038/onc.2009.112 · Cited by 165
Induction of Mxi1-SRα by FOXO3a Contributes to Repression of Myc-Dependent Gene Expression
Delpuech, O., Griffiths, B. L., East, P., Essafi, A., Lam, E. W. ‐., Burgering, B. M. T., Downward, J., & Schulze, A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01789-06 · Cited by 161
Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1α
Qing, G., Skuli, N., Mayes, P. A., Pawel, B., Martinez, D., Maris, J. M., & Simon, M. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0740 · Cited by 157
Self-citation
The B55α Subunit of PP2A Drives a p53-Dependent Metabolic Adaptation to Glutamine Deprivation
Reid, M. A., Wang, W.-I., Rosales, K. R., Welliver, M. X., Pan, M., & Kong, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.008 · Cited by 154
Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity
Bertino, J. R., Waud, W. R., Parker, W. B., & Lubin, M. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.7.14948 · Cited by 151
Lipophilic but not hydrophilic statins selectively induce cell death in gynecological cancers expressing high levels of HMGCoA reductase.
Kato, S., Smalley, S. V., Sadarangani, A., Chen-Lin, K., Oliva, B., Brañes, J. A., Jorge Carvajal, C., Gejman, R., Owen, G. I., & Cuello, M. A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00771.x · Cited by 150
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
Gan, B., Lim, C., Chu, G., Hua, S., Ding, Z., Collins, M. P., HU, J. L., Jiang, S., Fletcher-Sananikone, E., Zhuang, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.019 · Cited by 149
The MK5/PRAK Kinase and Myc Form a Negative Feedback Loop that Is Disrupted during Colorectal Tumorigenesis
Kress, T. R., Cannell, I. G., Brenkman, A. B., Samans, B., Gaestel, M., Roepman, P., Burgering, B. M. T., Bushell, M., Rosenwald, A., & Eilers, M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.023 · Cited by 148
Alteration of the lipid profile in lymphomas induced by MYC overexpression
Eberlin, L. S., Gabay, M., Fan, A. C., Gouw, A. M., Tibshirani, R. J., Felsher, D. W., & Zare, R. N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409778111 · Cited by 147
Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma
Zhou, W. H., Feng, X., Ren, C., Jiang, X., Liu, W., Huang, W., Liu, Z., Li, Z., Zeng, L., Wang, L., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-53 · Cited by 145
AKT1 and MYC Induce Distinctive Metabolic Fingerprints in Human Prostate Cancer
Priolo, C., Pyne, S., Rose, J. A., Regan, E. R., Zadra, G., Photopoulos, C., Cacciatore, S., Schultz, D., Scaglia, N., McDunn, J. E., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1490 · Cited by 138
Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival
Karnitz, L. M., Flatten, K. S., Wagner, J. M., Loegering, D. A., Hackbarth, J. S., Arlander, S. J. H., Vroman, B. T., Thomas, M. B., Baek, Y.-U., Hopkins, K. M., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012716 · Cited by 137
Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis
Jiang, J., Wang, J., Yue, M., Cai, X., Wang, T., Wu, C., Su, H., Wang, Y., Han, M., Zhang, Y., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.01.001 · Cited by 135
Self-citation
The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry
Morrish, F. M., Neretti, N., Sedivy, J. M., & Hockenbery, D. M. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5739 · Cited by 130
Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition
Fan, Y., Dickman, K. G., & Zong, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035584 · Cited by 119
c-Myc Programs Fatty Acid Metabolism and Dictates Acetyl-CoA Abundance and Fate
Edmunds, L. R., Sharma, L., Kang, A., Lu, J. L., Vockley, J., Basu, S., Uppala, R., Goetzman, E. S., Beck, M. E., Scott, D. K., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.580662 · Cited by 118
Proline Starvation Induces Unresolved ER Stress and Hinders mTORC1-Dependent Tumorigenesis
Sahu, N., Cruz, D. D., Gao, M., Sandoval, W. N., Haverty, P. M., Liu, J., Stéphan, J.-P., Haley, B., Classon, M., Hatzivassiliou, G., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.008 · Cited by 115
Effects of MYCN Antisense Oligonucleotide Administration on Tumorigenesis in a Murine Model of Neuroblastoma
Burkhart, C. A., Cheng, A. J., Madafiglio, J., Kavallaris, M., Mili, M., Marshall, G. M., Weiss, W. A., Khachigian, L. M., Norris, M. D., & Haber, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg045 · Cited by 108
Stress-induced cleavage of Myc promotes cancer cell survivalPreprint
Conacci‐Sorrell, M., Ngouenet, C., Anderson, S., Brabletz, T., & Eisenman, R. N. (2014) · Genes & Development · doi:10.1101/gad.231894.113 · Cited by 107
Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation
Wall, M., Poortinga, G., Hannan, K. M., Pearson, R. B., Hannan, R. D., & McArthur, G. A. (2008) · Blood · doi:10.1182/blood-2007-09-111856 · Cited by 105
Regulation of OGT by URI in Response to Glucose Confers c-MYC-Dependent Survival Mechanisms
Burén, S., Gomes, A. L., Teijeiro, A., Fawal, M.-A., Yilmaz, M., Tummala, K. S., Pérez‐Martínez, M., Rodriguez‐Justo, M., Campos‐Olivas, R., Megı́as, D., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.023 · Cited by 104
Tumor Dormancy and MYC Inactivation: Pushing Cancer to the Brink of Normalcy
Shachaf, C. M., & Felsher, D. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1172 · Cited by 103
Defining the specific physiological requirements for c-Myc in T cell development
Douglas, N. C., Jacobs, H. C., Bothwell, A. L. M., & Hayday, A. (2001) · Nature Immunology · doi:10.1038/86308 · Cited by 99
Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.
Bassiri, H., Benavides, A. D., Haber, M., Gilmour, S. K., Norris, M. D., & Hogarty, M. D. (2015) · PubMed Central · doi:10.3978/j.issn.2224-4336.2015.04.06 · Cited by 87
Mouse Genetics Suggests Cell-Context Dependency for Myc-Regulated Metabolic Enzymes during Tumorigenesis
Nilsson, L. M., Plym Forshell, T. Z., Rimpi, S., Kreutzer, C., Pretsch, W., Bornkamm, G. W., & Nilsson, J. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002573 · Cited by 85
Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2
Xiao, D., Ren, P., Su, H., Yue, M., Xiu, R., Hu, Y., Liu, H., & Qing, G. (2015) · Oncotarget · doi:10.18632/oncotarget.5821 · Cited by 80
Self-citation
MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer
Casciano, J. C., Perry, C. E., Cohen-Nowak, A. J., Miller, K. D., Voorde, J. V., Zhang, Q., Chalmers, S., Sandison, M. E., Liu, Q., Hedley, A., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0711-3 · Cited by 80
The MYC mRNA 3′‐UTR couples RNA polymerase II function to glutamine and ribonucleotide levels
Dejure, F. R., Royla, N., Herold, S., Kalb, J., Walz, S., Ade, C. P., Mastrobuoni, G., Vanselow, J. T., Schlösser, A., Wolf, E., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201796662 · Cited by 75
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer
Barfeld, S. J., Fazli, L., Persson, M., Marjavaara, L., Urbanucci, A., Kaukoniemi, K. M., Rennie, P. S., Ceder, Y., Chabes, A., Visakorpi, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3494 · Cited by 73
Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters
Gan, L., Xiu, R., Ren, P., Yue, M., Su, H., Guo, G., Xiao, D., Yu, J., Jiang, H., Liu, H., et al. (2015) · Oncogene · doi:10.1038/onc.2015.360 · Cited by 69
Self-citation
PAICS, a Purine Nucleotide Metabolic Enzyme, is Involved in Tumor Growth and the Metastasis of Colorectal Cancer
Agarwal, S., Chakravarthi, B. V. S. K., Behring, M. P., Kim, H., Chandrashekar, D. S., Gupta, N., Bajpai, P., Elkholy, A., Balasubramanya, S. A. H., Hardy, C., et al. (2020) · Cancers · doi:10.3390/cancers12040772 · Cited by 56
DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma
Koomoa, D. T., Geerts, D., Lange, I., Köster, J., Pegg, A. E., Feith, D. J., & Bachmann, A. S. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1835 · Cited by 55
Growth-inhibitory effects of DL-alpha-difluoromethylornithine in the spectrum of human lung carcinoma cells in culture.
Luk, G. D., Goodwin, G., Gazdar, A. F., & Baylin, S. B. (1982) · PubMed · Cited by 49
Characterization of MYC-Induced Tumorigenesis by in Situ Lipid Profiling
Perry, R. H., Bellovin, D. I., Shroff, E. H., Ismail, A. I., Zabuawala, T., Felsher, D. W., & Zare, R. N. (2013) · Analytical Chemistry · doi:10.1021/ac400479j · Cited by 40
B Lymphocyte Commitment Program Is Driven by the Proto-Oncogene c-myc
Vallespinós, M., Fernández‐Antorán, D., Rodríguez, L., Álvaro-Blanco, J., Baena, E., Ortiz, M., Dukovska, D., Martínez, D., Rojas, A. M., Campanero, M. R., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002753 · Cited by 38
HMGCR is necessary for the tumorigenecity of esophageal squamous cell carcinoma and is regulated by Myc
Zhong, C., Fan, L., Yao, F., Shi, J., Fang, W., & Zhao, H. (2014) · Tumor Biology · doi:10.1007/s13277-013-1539-8 · Cited by 38
Critical Roles of Myc-ODC Axis in the Cellular Transformation Induced by Myeloproliferative Neoplasm-Associated JAK2 V617F Mutant
Funakoshi‐Tago, M., Sumi, K., Kasahara, T., & Tago, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052844 · Cited by 36
Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma
Chaturvedi, N. K., Mahapatra, S., Kesherwani, V., Kling, M. J., Shukla, M., Ray, S., Kanchan, R. K., Perumal, N., McGuire, T. R., Sharp, J. G., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6291-z · Cited by 34
Coordination of glucose and glutamine utilization by an expanded Myc network
Kaadige, M. R., Elgort, M., & Ayer, D. E. (2010) · Transcription · doi:10.4161/trns.1.1.12142 · Cited by 31
A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung Adenocarcinoma
Kaufman, J. M., Yamada, T., Park, K., Timmers, C. D., Amann, J. M., & Carbone, D. P. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1639 · Cited by 31
MYC predetermines the sensitivity of gastrointestinal cancer to antifolate drugs through regulating TYMS transcription
Liu, T., Han, Y., Yu, C., Ji, Y., Wang, C., Chen, X., Wang, X., Shen, J., Zhang, Y., & Lang, J. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.003 · Cited by 30
Metabolic analysis reveals evidence for branched chain amino acid catabolism crosstalk and the potential for improved treatment of organic acidurias
McCalley, S., Pirman, D. A., Clasquin, M. F., Johnson, K. R., Jin, S., & Vockley, J. E. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.05.008 · Cited by 26
Abstract CT153: First in human study of the first-in-class fatty acid synthase (FASN) inhibitor TVB-2640
Falchook, G. S., Patel, M. R., Infante, J. R., Arkenau, H., Dean, E. J., Brenner, A. J., Borazanci, E. H., Lopez, J. S., Moore, K. N., Schmid, P., et al. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-ct153 · Cited by 25
Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
Feleszko, W., & Jakóbisiak, M. (2000) · PubMed · Cited by 23
Tacalcitol increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating the thymidylate synthase
Milczarek, M., Rossowska, J., Kłopotowska, D., Stachowicz-Suhs, M., Kutner, A., & Wietrzyk, J. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.017 · Cited by 23
Bag‐1 promotes cell survival through c‐Myc‐mediated ODC upregulation that is not preferred under apoptotic stimuli in MCF‐7 cells
Ozfiliz-Kilbas, P., Kizilboga, T., Demir, S., Alkurt, G., Palavan-Ünsal, N., Arısan, E. D., & Doğanay, G. D. (2015) · Cell Biochemistry and Function · doi:10.1002/cbf.3114 · Cited by 18

Sorted by citations

The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
Dhanasekaran, R., Deutzmann, A., Mahauad‐Fernandez, W. D., Hansen, A. S., Gouw, A. M., & Felsher, D. W. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00549-2 · Cited by 1,044
Nucleotide metabolism: a pan-cancer metabolic dependency
Mullen, N. J., & Singh, P. K. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00557-7 · Cited by 502
The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives
Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00659-4 · Cited by 369
Amino acid metabolism in tumor biology and therapy
Chen, J., Cui, L., Lu, S., & Xu, S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06435-w · Cited by 277
Causal integration of multi‐omics data with prior knowledge to generate mechanistic hypotheses
Dugourd, A., Kuppe, C., Sciacovelli, M., Gjerga, E., Gabor, A., Emdal, K. B., Vieira, V., Bekker‐Jensen, D. B., Kranz, J., Bindels, E. M. J., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209730 · Cited by 149

See all 405

Authors: Dong, Y., Tu, R., Liu, H., & Qing, G.
Affiliations: Wuhan University (CN)
Corresponding author: Qing, Guoliang
ORCID: Dong, Yang
Tu, Rongfu
Liu, Hudan
Qing, Guoliang
Venue: Signal Transduction and Targeted Therapy
Publisher: Springer Science and Business Media LLC
Published: 2020-07-10
Volume: 5
Issue: 1
Pages: 124-124
ISSN: 2059-3635 (ISSN-L)
DOI: 10.1038/s41392-020-00235-2
PMC: PMC7351732
OpenAlex: W3041824636
Cited by: 405
References: 120
Citations by year: 2026: 84 · 2025: 87 · 2024: 71 · 2023: 48 · 2022: 58 · 2021: 51 · 2020: 6
FWCI: 4.15
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (81830084, 81725013)
Wuhan University (TFJC2018005)
Fundamental Research Funds for the Central Universities (2042020kf0215)
National Science Fund for Distinguished Young Scholars (81725013)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: c-Myc, cancer metabolism, metabolic reprogramming, malignant transformation, cancer therapeutics, metabolic dependencies
MeSH terms: Animals, Cell Transformation, Neoplastic, Humans, Neoplasms, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins c-myc

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regulation of cancer cell metabolism: oncogenic MYC in the driver’s seat

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks